Plain-English translation of NCT06647589 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a form of psychotherapy called acceptance and commitment therapy (ACT) to see if it can help people who experience obsessive-compulsive disorder focused on religious or moral concerns. The study will give participants twelve weeks of one-on-one therapy sessions using this approach. Researchers want to understand whether this treatment works and is practical for this specific type of OCD.
Religious obsessive-compulsive disorder can be particularly distressing because intrusive thoughts conflict with someone's deeply held faith and values. This trial exists to find out whether this therapy approach, which focuses on accepting difficult thoughts rather than fighting them, can reduce suffering and help people live more meaningful lives aligned with their beliefs.
You likely qualify if…
You likely don't qualify if…
You would attend therapy sessions once a week for twelve consecutive weeks. During each session, a therapist trained in acceptance and commitment therapy will work with you to help you learn new ways of relating to your obsessive thoughts and worries—rather than trying to eliminate them. The sessions will focus on helping you clarify what matters most to you in your faith and values, and move toward a more meaningful life despite the presence of difficult thoughts.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Sponsor
University of Alabama at Birmingham
Enrollment target
~10 participants
Started
July 2025
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
David Johnson
University of Alabama at Birmingham
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.